Skip to Main Content

President Jim Clements

  • sam patrick posted an article
    Governor salutes industry as record-setting SC life sciences conference starts see more

    In recognition of the importance of the life sciences industry in South Carolina, Governor Henry McMaster has issued a proclamation recognizing February 21-25, 2022 as South Carolina Life Sciences Week in the Palmetto State.

    Governor McMaster issued the proclamation just as SCBIO organizers are putting finishing touches on the largest-ever life sciences gathering ever held in the state.  More than 500 registrants live and virtual from across America and around the globe will attend the SCBIO-led gathering of South Carolina’s life sciences community this week in Charleston – and will celebrate the contributions of its 700+ organizations in helping America and the world overcome the challenging COVID-19 pandemic.

    In his proclamation, Governor McMaster highlighted the rapid growth of the cutting-edge industry in South Carolina and its reputation as an emerging force in life sciences.  He specifically cited the industry’s efforts in workforce development, its emerging role in research and development, and its ability to attract high quality and high-paying jobs and investment to the Palmetto State.

    Governor McMaster issued the proclamation as hundreds of life science executives from 27 states and six countries prepare to assemble in Charleston, SC for SCBIO 2022: The Life Sciences Conference of South Carolina. Charleston and the Lowcountry feature a strong concentration of life science companies, while the industry boasts life sciences organizational presence in 42 of South Carolina’s 46 counties. Among more than 35 featured presenters at the conference will be BIO’s global CEO Dr. Michelle McMurry-Heath, Clemson University President Jim Clements, PhRMA executive Courtney Christian, Nephron Pharmaceuticals CEO Lou Kennedy, and SC Commerce Secretary Harry Lightsey III.  SCBIO President and CEO James Chappell will deliver a highly anticipated State of the Industry address on the opening day of the Conference.

    Among many highlights of the Conference will be the unveiling of a new Economic Impact Study for the state’s life sciences industry, a study last conducted in 2017 that revealed the sizable impact of the industry, including an$11 billion economic impact, more than 700 firms, and over 33,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products.  Officials familiar with the just-completed study indicate the new results could be “significantly higher” despite the pandemic’s economic body blows.

    Life sciences today represents a key economic development focus for the state, with strong life science recruiting initiatives led by the South Carolina Department of Commerce and other regional economic development teams. Governor McMaster issued an Executive Order in April 2021 for the state to make life sciences a strategic focus for South Carolina in its recruiting and economic development priorities.

    “Life sciences is a major driver of South Carolina’s economy today, and this conference is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and country,” noted SCBIO President and CEO James Chappell. “We’re honored by Governor McMaster’s recognition and appreciate his personal support for the contributions that life sciences are making to improve quality of life, care and economic standing for South Carolina citizens.”

    For additional information on SCBIO or to register for SCBIO 2022, visit www.SCBIO.org

    Proclamation:

    WHEREAS,    South  Carolina  has  cultivated  a  cutting-edge  life  sciences  sector  with  an  annual  economic  impact  of  more  than  25  billion  dollars;  and

    WHEREAS,    more  than  1,000  firms  and  over  87,000  professionals  are  involved  in  the  research,  development,  and  commercialization  of  innovative  healthcare,  medical  device,  industrial,  environmental,  and  agricultural  biotechnology  products;  and

    WHEREAS,    since  2017,  the  life  sciences  sector  has  become  South  Carolina’s  fastest-growing  industry,  with  employment  growing  at  double  the  rate  of  South  Carolina’s  economy;  and

    WHEREAS,    SCBIO  is  the organization  exclusively  focused  on  attracting  new  life  science  sector  jobs  and  investment  to  South  Carolina;  and

    WHEREAS,    during  the  COVID-19  pandemic,  more  than  100  life  sciences  organizations  across  South  Carolina  worked  together  to  support  and  promote  the  procurement  and  distribution  of  personal  protective  equipment,  support  and  implement  COVID-19  testing,  and  expedite  health  solutions  for  our  citizens;  and

    WHEREAS,    in  collaboration  with  the  South  Carolina  Department  of  Commerce  and  SCBIO,  South  Carolina’s  economic  development  recruitment  efforts  shall  include  an  enhanced  emphasis  and  focus  on  attracting,  building,  advancing,  innovating,  and  growing  existing  and  new  life  sciences  businesses  in  the  state.

    NOW,  THEREFORE,  I,  Henry  McMaster,  Governor  of  the  great  State  of  South  Carolina,  do  hereby  proclaim  February  21 – 25,  2022,  as

    SCBIO  life  sciences  week

    throughout the state and encourage  all  South  Carolinians  to  recognize  and  appreciate  the many  contributions  of  the  life  sciences  industry  to  South  Carolina’s  health  and  economic  prosperity.

  • sam patrick posted an article
    Core industry grew faster in SC than any Southeastern state from 2017 – 2020, at double region’s rat see more

    On the heels of the proclamation by Governor Henry McMaster that  he was recognizing February 21-25 as SC Life Sciences Week in recognition of the importance of the industry to South Carolina, researchers from the Moore School of Business at the University of South Carolina have determined that the industry is not only South Carolina’s fastest-growing overall – it is growing at a faster rate than its peers across the Southeast.

    Since 2010, annual employment growth within the life science industry core has averaged approximately 2.7 percent, far exceeding that of the state as a whole over the same time period (1.4%). More recently, although South Carolina’s overall employment growth experienced a slight decrease since 2017 due to the pandemic-induced recession of 2020 (-0.4%), the life science industry core experienced remarkably high growth of 26.4 percent over the same period according to Bureau of Labor Statistics data – and an even higher rate of 42.2% using proprietary South Carolina data.

    These growth rates are unparalleled in the region, researchers noted. The life science industry core grew faster in South Carolina than in any other Southeastern state between 2017 and 2020 and at approximately twice the rate of the Southeastern region as a whole. South Carolina’s life science industry core currently ranks 5th among all Southeastern states in total size, behind Florida, North Carolina, Tennessee, and Georgia.

    The research went on to document that the annual economic impact of the life science industry on the state of South Carolina totals a robust $25.7 billion. This figure reflects the dollar value of all goods and services that can be attributed (either directly or indirectly) to life science-related firms in South Carolina. This $25.7 billion in economic output is associated with 87,773 total jobs and over $5.6 billion in labor income – and a sizable jump from the $11.4 billion impact in a late 2016 study.

    The economic impact resulting from the life science industry is associated with an employment multiplier of 2.9, which implies that for every 10 jobs that are created within the life science industry in South Carolina, an additional 19 jobs are created elsewhere in the state. This multiplier effect is substantially higher than that of the average South Carolina industry multiplier, which is 1.7.

    The life science industry in South Carolina currently consists of approximately 30,731 employees across 1,033 firms. Employment is most concentrated within firms specializing in medical devices & equipment manufacturing and bioscience-related distribution. When the indirect and induced impact of the industry is considered, the life sciences industry here accounts for a staggering 87,773 jobs, researchers note.

    Better still, the average direct job in the life science industry in South Carolina pays an annual total wage of $87,639, which represents a 79 percent premium over the average annual wage in South Carolina across all jobs ($48,942). And the industry supports a significant demand for high-wage, high-skilled jobs in various STEM fields (science, engineering, technology, mathematics, and related occupations). Approximately 26 percent of the life science industry statewide is driven by high-tech R&D, with another 33 percent in production-related activities, and the remaining 41 percent providing transportation and other support services.

    Even the growth of the firm count is extraordinary, having grown from 402 firms counted in the Palmetto State in the 2016 study to 1,033 firms today in the rapidly expanding ecosystem. And life sciences impact the entire state, with a current presence of industry organizations in 42 of 46 state counties.

    The research, led by Research Economist Joseph Von Nessen, further noted that industries grow over time, and those able to maximize the economic impact of their growth and add the most value to their local regions are typically those that focus on expanding their R&D subsectors. This bodes well for South Carolina life sciences because the high-tech R&D subsector is projected to be the fastest growing segment of life sciences over the next decade. This total anticipated growth rate of 18.4 percent exceeds projections for the broader life sciences sector and reveal significant potential for South Carolina life sciences – namely, the ability to capitalize on the projected economic growth trends that already signal strong demand for R&D.

    The findings were presented as hundreds of life science executives from 27 states and six countries assembled in Charleston, SC for SCBIO 2022: The Life Sciences Conference of South Carolina. Among more than 35 featured presenters at the conference were BIO’s global CEO Dr. Michelle McMurry-Heath, Clemson University President Jim Clements, PhRMA executive Courtney Christian, Nephron Pharmaceuticals CEO Lou Kennedy, and SC Commerce Secretary Harry Lightsey III.  SCBIO President and CEO James Chappell delivered a State of the Industry review and outlook as well.

    Life sciences today represents a key economic development focus for the state, with strong life science recruiting initiatives led by the South Carolina Department of Commerce and other regional economic development teams. Governor McMaster issued an Executive Order in April 2021 for the state to make life sciences a strategic focus for South Carolina in its recruiting and economic development priorities.

    “Life sciences is a major driver of South Carolina’s economy today, and this conference is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and country,” noted SCBIO President and CEO James Chappell. “We’re honored by Governor McMaster’s personal support for the contributions that life sciences are making to improve quality of life, care and economic standing for South Carolina citizens.”

    For additional information on SCBIO, visit www.SCBIO.org.

  • sam patrick posted an article
    Top Speakers Added for SCBIO 2019 Life Sciences Conference in Greenville October 29-31 see more

    Come Ignite the Future of South Carolina life sciences and join hundreds of industry executives, leaders in government and higher education, and life sciences providers and supporters from across America at SCBIO 2019... October 29-31 in Greenville, SC!

    SCBIO 2019 features 2+ days of incredible presentations, intensive networking, innovation updates, opportunity discovery, partnership making, industry trade show and strategic discussion.  SCBIO 2019 is a must-attend for America's most promising and prominent life sciences organizations! 

    Meet and hear such speakers at Michal Preminger, head of Johnson & Johnson Innovation for North America... Halle Tecco, founder of Natalist and digital health venture fund Rock Health... President Jim Clements of Clemson University... inspirational success story Dean Otto, whose very life was saved by contributions from the industry we share... and dozens more!

    Enjoy world-class accommodations at the Hyatt Regency Greenville... incredible receptions Tuesday (presented by Prisma Health System) and Wednesday (presented by the Greenwood Partnership, Greenville Area Development Corp. and City of Greenville) evenings... and leading-edge discussions on such topics as: 

         -  Turning Education & Research Into Cures & Companies
         -  Building the Life Sciences Workforce of Tomorrow
         -  Igniting & Investing in the Changing Future of Healthcare
         -  Life Sciences Economic Development:  How SC Will Win
         -  Opportunities & Innovations in Life Sciences
         -  Global Trends and Their Implications for You
         -  South Carolina Success Stories & The Leaders Behind Them

    Registration is now open!  Enjoy Early Bird registration and save $100 or more by booking right now. And secure your spot at our headquarters hotel with accommodations at Hyatt Regency Greenville at special rates while they last. 

  • sam patrick posted an article
    Clemson and Arthrex are launching a program to teach students and support the med device industry see more

    The surgical device industry is continuously growing and evolving. According to data from GlobalData, the orthopedics market is expected to grow to $66 billion by 2023 from $52.8 billion in 2017.  In South Carolina, medical devices are an anchor of the state's fast-growing and globally respected life sciences industry, according to executives with SCBIO -- the Palmetto State's life sciences industry organization and champion.

    In response to this upward trend, surgical device companies are seeking more employees with a specialized skillset, and thanks to a new partnership with Arthrex Inc., Clemson University students will be equipped to answer the call.

    A global leader in minimally invasive orthopedics, Arthrex already works with Clemson on a number of research projects. Now it’s expanding its engagement with the university through a new, two-year pilot program developed with the needs of the surgical device industry in mind and a generous gift of ten $7,500 scholarships.

    “Arthrex is one of the university’s valuable strategic partners, and this opportunity to work together to create programming unique to Clemson speaks volumes about what the company thinks of our talented faculty and students,” said Clemson President James P. Clements. “This partnership is another example of Clemson’s ongoing commitment to the state of South Carolina, and I am grateful to Arthrex for its generous gift, which will enable our students to work with a world-class company to develop skills that are vital to the surgical device industry.” 

    “Arthrex takes great pride in its commitment to education and we are pleased to help develop the next generation of highly skilled professionals like Arthrex Technology Consultants who work with orthopedic surgeons to provide trustworthy technical product support,” said Arthrex President and founder Reinhold Schmieding.

    In October 2017, Arthrex announced plans for a new $40 million facility in Sandy Springs, South Carolina. Surgical devices will be manufactured in the 290,000-square-foot facility, which is scheduled to open this summer. The new location is part of Arthrex’s efforts to expand its manufacturing base into South Carolina to create new products and jobs in America.

    The pilot program will span two years and comprise a series of courses, Arthrex internships and additional learning opportunities for rising third-year students majoring in bioengineering, marketing and health sciences departments.

    MKT 4950 Developing and Selling Medical Devices is the first course being offered in the series and will begin in fall 2019. Taught by Ryan Mullins in the College of Business, course material provides students an introduction to the health care industry with a focus on the development and marketing of surgical device innovations. Mullins was selected to develop the course as the Provost’s Inaugural Innovation Fellow, a program created to encourage faculty on campus to support corporate engagement efforts.

    “Our collaboration with Arthrex helps us create a new type of focused course,” said Mullins. “We will walk students through real case studies at Arthrex to understand how surgical devices get translated from marketable idea to surgeon or physician adoption. This helps us illustrate the challenges inherent to both the health care marketplace and marketing of new offerings, which is not taught anywhere else.”

    Students who are enrolled in the course may apply for the scholarship and additional programs offered as part of the two-year series of courses. Those who would like to participate in the entire program will take Student Affairs’ Certified Student Leader Program in the spring and an internship with Arthrex in the summer. Students outside of the participating departments can also intern with Arthrex by working with their advisers and the career center.

    This partnership was developed through Clemson’s Office of Corporate Partnerships and Strategic Initiatives. Additional details regarding the scholarship, internship and second-year courses will be available soon.